Intervention not reported
Clinically apparent hepatitis A (low risk of bias trials) Dienstag 1999 · patients with preventing hepatitis A.
The intervention leads to lower clinically apparent hepatitis A (low risk of bias trials) Dienstag… (high certainty).
1 finding from 1 review
Intervention not reported
Clinically apparent hepatitis A (low endemicity) low risk of bias Dienstag 1999 · patients with preventing hepatitis A.
The intervention leads to lower clinically apparent hepatitis A (low endemicity) low risk of bias… (high certainty).
1 finding from 1 review
Intervention not reported
Clinically apparent hepatitis A (low endemicity) all included trials Dienstag 1999 · patients with preventing hepatitis A.
The intervention leads to lower clinically apparent hepatitis A (low endemicity) all included trials… (high certainty).
1 finding from 1 review
Intervention not reported
Clinically apparent hepatitis A (high endemicity) low risk of bias Dienstag 1999 · patients with preventing hepatitis A.
The intervention leads to lower clinically apparent hepatitis A (high endemicity) low risk of bias… (high certainty).
1 finding from 1 review
Intervention not reported
Clinically apparent hepatitis A (single dose regimen) low risk of bias Dienstag 1999 · patients with preventing hepatitis A.
The intervention leads to lower clinically apparent hepatitis A (single dose regimen) low risk of… (high certainty).
1 finding from 1 review
Intervention not reported
Clinically apparent hepatitis A (multiple doses) low risk of bias Dienstag 1999 · patients with preventing hepatitis A.
The intervention leads to lower clinically apparent hepatitis A (multiple doses) low risk of bias… (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality low risk of bias Mortality · patients with preventing hepatitis A.
The intervention showed no clear difference in all‐cause mortality low risk of bias Mortality (high certainty).
1 finding from 1 review
Intervention not reported
Clinically apparent hepatitis A (inactivated HAV vaccines) low risk of bias trials Dienstag 1999 · patients with preventing hepatitis A.
The intervention leads to lower clinically apparent hepatitis A (inactivated HAV vaccines) low risk… (high certainty).
1 finding from 1 review
Intervention not reported
Lack of sero‐protection, (anti HAV IgG < 10mIU/L) (low risk of bias) Maiwald 1997 · patients with preventing hepatitis A.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Lack of sero‐protection, (anti HAV IgG < 20mIU/L) (low risk of bias ) Maiwald 1997 · patients with preventing hepatitis A.
The intervention leads to lower lack of sero‐protection, (anti HAV IgG < 20mIU/L) (low risk of bias… (high certainty).
1 finding from 1 review
Intervention not reported
Non‐serious local adverse events (low risk of bias) inactivated HAV vaccine ICH‐GCP 1997 · patients with preventing hepatitis A.
The intervention showed no clear difference in non‐serious local adverse events (low risk of bias) inactivated HAV… (high certainty).
1 finding from 1 review
Intervention not reported
Non‐serious systemic adverse events (low risk of bias) inactivated HAV vaccine ICH‐GCP 1997 · patients with preventing hepatitis A.
The intervention showed no clear difference in non‐serious systemic adverse events (low risk of bias) inactivated… (high certainty).
1 finding from 1 review
Intervention not reported
Non‐serious local adverse events (low risk of bias) live attenuated HAV vaccine ICH‐GCP 1997 · patients with preventing hepatitis A.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Non‐serious systemic adverse events (low risk of bias) live attenuated HAV vaccine ICH‐GCP 1997 · patients with preventing hepatitis A.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Clinically apparent hepatitis A (live attenuated HAV vaccines) low risk of bias Dienstag 1999 · patients with preventing hepatitis A.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Clinically apparent hepatitis A (Dose of live attenuated HAV vaccine, titre >= TCID50 ) low risk of bias Dienstag 1999 · patients with preventing hepatitis A.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Clinically apparent hepatitis A (Dose of live attenuated HAV vaccine, titre < TCID50 ) low risk of bias Dienstag 1999 · patients with preventing hepatitis A.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality ‐ not reported · adults undergoing intra‐ and transperitoneal laparoscopic procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life ‐ not reported · adults undergoing intra‐ and transperitoneal laparoscopic procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term serious adverse events (SAEs) · adults undergoing intra‐ and transperitoneal laparoscopic procedures
It is very uncertain whether summary of findings table ‐ Deep neuromuscular blockade (NMB) changes short‐term serious adverse events (SAEs) compared with shallow NMB (very low certainty).
1 finding from 1 review